Globeflex Capital L P Emergent Bio Solutions Inc. Transaction History

Globeflex Capital L P

$592 Million
Q3 2025

A detailed history of Globeflex Capital L P transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Globeflex Capital L P holds 241,298 shares of EBS stock, worth $2.44 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

241,298

Holding current value

$2.44 Million

% of portfolio

0.36%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$5.63 - $9.32 $1.36 Million - $2.25 Million	241,298 New	241,298 $2.13 Million
Q3 2021 Nov 12, 2021	SELL	$50.07 - $66.05 $294,311 - $388,241	-5,878 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$56.61 - $80.46 $542,323 - $770,806	-9,580 Reduced 61.97%	5,878 $370,000
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $125,895 - $182,777	-1,460 Reduced 8.63%	15,458 $1.44 Million
Q4 2020 Feb 11, 2021	BUY	$79.17 - $111.47 $12,588 - $17,723	159 Added 0.95%	16,918 $1.52 Million

Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $350,656 - $577,678	-4,281 Reduced 20.35%	16,759 $1.73 Million
Q2 2020 Aug 12, 2020	SELL	$54.33 - $89.52 $9,670 - $15,934	-178 Reduced 0.84%	21,040 $1.66 Million
Q1 2020 May 13, 2020	SELL	$49.34 - $68.76 $116,195 - $161,929	-2,355 Reduced 9.99%	21,218 $1.23 Million
Q2 2019 Aug 12, 2019	SELL	$39.92 - $53.86 $1,077 - $1,454	-27 Reduced 0.11%	23,573 $1.14 Million
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $111 - $146	2 Added 0.01%	23,600 $1.4 Million
Q3 2018 Nov 09, 2018	SELL	$52.05 - $66.51 $20,611 - $26,337	-396 Reduced 1.65%	23,598 $1.55 Million
Q2 2018 Aug 10, 2018	SELL	$48.33 - $55.64 $188,390 - $216,884	-3,898 Reduced 13.98%	23,994 $1.21 Million
Q1 2018 May 14, 2018	BUY	$44.44 - $54.39 $931,817 - $1.14 Million	20,968 Added 302.83%	27,892 $1.47 Million
Q4 2017 Feb 13, 2018	BUY	$37.77 - $47.75 $261,519 - $330,621	6,924	6,924 $322,000

Others Institutions Holding EBS

# of Institutions

191

Shares Held

41.3M

Call Options Held

899K

Put Options Held

256K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $504M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.

Account

Globeflex Capital L P Emergent Bio Solutions Inc. Transaction History